• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    NewAge Announces Record Second Quarter Results: Net Revenue Increases 98% to $124 Million

    8/9/21 4:58:15 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $NBEV alert in real time by email

    DENVER, Aug. 09, 2021 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), the Colorado-based direct-to-consumer (D2C) organic and healthy products company, today announced record financial results for the second quarter of 2021 with a net revenue of $124 million, net income of $17.4 million, adjusted EBITDA1 of $1.7 million, and basic earnings per share of $0.11.

    For the three months ending June 30, 2021, net revenue was $124 million, an increase of $61 million or 98%. Gross profit for the quarter was $84 million, an increase of $46 million or 120%, resulting in a gross margin of 67.6%, compared to a 60.8% in the prior-year period, an increase of 6.8 percentage points. Net income was $17.4 million, an increase of $26.9 million compared ot a net loss of ($9.6) million in the prior-year period. Adjusted EBITDA was $1.7 million, an increase of $7.2 million compared to a loss of ($5.5) million in the prior-year period. Basic earnings per share was a positive $0.11, an increase of $0.21 compared to a loss of ($0.10) in the prior-year period.

    Brent Willis, Chief Executive Officer of NewAge, commented, "The second quarter saw accelerated top and bottom-line results and continued income statement improvement. In the quarter, we completed the Aliven acquisition, had a very successful annual meeting, further integrated ARIIX capturing additional cost and revenue synergies, and continued expansion of our social selling initiatives worldwide. We strengthened our team and positioned NewAge for even further transformative performance as our strategy unfolds."  

    "This is our third consecutive quarter of positive adjusted EBITDA," commented Kevin Manion, NewAge's new Chief Financial Officer. "Financially, our focus is on developing, utilizing and driving consistent company-wide metrics to improve EBITDA margins through operational improvements and reducing SG&A costs, specifically from consolidating the recent acquisitions. With these activities, we are confident in continued growth throughout 2021 and thereafter. I see NewAge as extremely well positioned to deliver superior organic growth and transformative, accretive external growth. I have spent most of my career in the consumer goods industry and see the NewAge Social Selling Network and our D2C route-to-market as the new winning industry model that will deliver outsized returns for shareholders."

    Second Quarter 2021 Financial Results        

    Net revenue was $124 million for the three months ending June 30, 2021, versus $63 million for the second quarter of the prior year, an increase of 98%. The growth in net revenue was driven by the acquisitions of ARIIX and Aliven. Leading the growth on a proforma basis was the combined European business that increased 24% and the United States business that increased 15%. These were offset by China, Japan and the impact of COVID-19 in a number of markets around the world.

    Gross margin for the second quarter of 2021 was $84 million or 67.6% of net revenue compared with $38 million or 60.8% of net revenue for the prior-year period, a 120% increase of $46 million and an increase of 6.8 gross margin percentage points. The gross margin percentage increase was driven by higher net revenue from the Direct/Social Selling Division and the disposition of the retail brands' business completed in September 2020. 

    Net operating loss was ($9.6) million for the second quarter of 2021 compared to a loss of ($8.8) million for the prior-year period. Net income was $17.4 million, correlating to a positive basic EPS of $0.11 per share, an increase of 21 cents from the prior-year period. Adjusted EBITDA was $1.7 million, compared with ($5.5) million for the prior-year period, an improvement of $7.2 million.

    The company ended the quarter with a strong balance sheet, with cash and cash equivalents of $92 million and debt of $31.5 million, exclusive of operating lease liabilities. Subsequent to the quarter-end, $9.7 million of debt was forgiven.

    "Our second-quarter results demonstrated commendable progress converging our companies and capturing both revenue and cost synergies. Carrying this momentum forward, we expect continued strong results from operations throughout the year as we build out additional platforms and programs for our global sales force. We believe we are stronger and better positioned than we have ever been, with differentiated health and wellness brands and an on-trend D2C business system, with an expanding e-commerce Subscriber base and an increasing and strengthening team of exclusive Brand Partner influencers," concluded Mr. Willis.

    Conference Call

    The company will host a live conference call and webcast today at 5:00 p.m. Eastern Time. Conference call details are provided below. Interested investors can dial into the conference call to hear the details of management's updates and participate in a question and answer session.

    Date: Monday, August 9, 2021

    Time: 5:00 p.m. ET

    Toll-free dial-in number: 1-855-327-6838

    International dial-in number: 1-604-235-2082

    Conference ID: 10016023

    The conference call will also be broadcast live and available for replay here and via the Investors section of the company's website at newage.com. The webcast replay will be available for approximately 45 days following the call.

    Please dial into the conference call 15 minutes prior to the start time due to increased demand for conference calls. You will be asked to register your name and organization.

    A replay of the conference call will be available after 8:00 p.m. Eastern Time on the same day through Monday, August 16, 2021, 11:59 p.m.

    Toll-free replay number: 1-844-512-2921

    International replay number: 1-412-317-6671

    Replay ID: 10016023

    About NewAge, Inc.

    NewAge is a purpose-driven firm dedicated to inspiring the planet to Live Healthy™. Colorado-based NewAge commercializes a portfolio of organic and healthy products worldwide through primarily a direct-to-consumer (D2C) route to market distribution system across more than 75 countries. The company competes in three major category platforms: Health and Wellness, Inner and Outer Beauty and Nutritional Performance and Weight Management — leading a network of more than 400,000 exclusive independent Brand Partners, empowered with the leading social selling tools and technology around the world.

    The company operates the websites NewAge.com, MaVie.com and Zennoa.com.  

    Safe Harbor Disclosure

    This press release contains forward-looking statements that are made under the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are any statement reflecting management's expectations regarding future results of operations, economic performance, and financial condition, including statements related to operating margins, the acquisitions and integrations of ARIIX and Aliven and cost synergies and operational efficiencies related thereto, the acquisition of additional businesses, the impact of the coronavirus ("COVID-19") pandemic, and plans for company growth. Forward-looking statements, specifically those concerning future performance, are subject to certain risks and uncertainties, and actual results may differ materially. NewAge competes in a rapidly growing and transforming industry, and risk factors, including those disclosed in the company's filings with the Securities and Exchange Commission, might affect the company's operations. Unless required by applicable law, the company undertakes no obligation to update or revise any forward-looking statements.

    For investor inquiries about NewAge please contact:

    NewAge Investor Relations:



    Mindy Eardley

    Director, Public and Investor Relations

    Tel: 1-801-573-4818

    [email protected]



    -

    NewAge, Inc.
    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
    (In thousands, except per share amounts)
          
     June 30,  December 31, 
    ASSETS2021  2020 
          
    Current assets:     
    Cash and cash equivalents$          80,922  $           43,711 
    Trade accounts receivable, net of allowance of $590 and $582, respectively10,470  12,341 
    Inventories44,219  48,051 
    Assets held for sale7,088  - 
    Current portion of restricted cash5,568  10,000 
    Prepaid expenses and other             13,086                13,032 
          
    Total current assets161,353  127,135 
          
    Long-term assets:     
    Identifiable intangible assets, net of accumulated amortization164,093  169,611 
    Goodwill55,281  54,993 
    Right-of-use lease assets29,741  38,764 
    Property and equipment, net of accumulated depreciation23,771  28,076 
    Restricted cash, net of current portion5,969  11,524 
    Deferred income taxes7,476  7,782 
    Deposits and other               4,771                  5,297 
          
    Total assets$         452,455  $          443,182 
          
    LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS' EQUITY     
    Current liabilities:     
    Accounts payable$          17,111  $           22,774 
    Accrued liabilities65,009  70,007 
    Operating lease liability related to right-of-use assets held for sale4,707  - 
    Current portion of business combination liabilities1,140  11,750 
    Current maturities of long-term debt             19,440                18,016 
          
    Total current liabilities107,407  122,547 
          
    Long-term liabilities:     
    Business combination liabilities, net of current portion49,013  95,826 
    Long-term debt, net of current maturities12,063  16,181 
    Operating lease liabilities, net of current portion:     
    Lease liability26,745  34,788 
    Deferred lease financing obligation15,543  15,882 
    Warrant derivative liability5,695  - 
    Deferred income taxes5,091  5,391 
    Other               8,295                  8,313 
          
    Total liabilities           229,852              298,928 
          
    Redeemable Common Stock, 800 shares as of December 31, 2020                       -                  2,101 
          
    Stockholders' equity:     
    Preferred stock, $0.001 par value per share. Authorized 1,000 shares; no shares issued-  - 
    Common Stock, $0.001 par value per share. Authorized 400,000 and 200,000 shares as of June 30, 2021 and December 31, 2020, respectively; issued and outstanding 136,606 and 99,146 shares as of June 30, 2021 and December 31, 2020, respectively137  99 
    Additional paid-in capital340,937  236,732 
    Obligation to issue 14,551 and 19,704 shares of Common Stock as of June 30, 2021 and December 31, 2020, respectively30,263  54,186 
    Note receivable for stock subscription-  (1,250)
    Accumulated other comprehensive income3,478  4,201 
    Accumulated deficit         (152,212)            (151,815)
    Total stockholders' equity           222,603              142,153 
    Total liabilities, redeemable Common Stock,  and stockholders' equity$         452,455  $          443,182 
          



    NewAge, Inc.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share amounts)

                
     Three Months Ended Six Months Ended
     June 30, June 30,
     2021  2020  2021  2020 
                
    Net revenue$124,040  $62,637  $249,558  $126,330 
    Cost of goods sold40,241  24,559  78,358  46,728 
                
    Gross profit83,799  38,078  171,200  79,602 
                
    Operating expenses:           
    Commissions43,320  18,405  90,717  37,920 
    Selling, general and administrative41,042  26,277  79,901  56,885 
    Depreciation and amortization expense4,723  1,761  9,398  3,542 
    Loss on disposal of Divested Business4,339  -  4,339  - 
    Impairment of right-of-use assets-  400  -  400 
                
    Total operating expenses93,424  46,843  184,355  98,747 
                
    Operating loss(9,625) (8,765) (13,155) (19,145)
                
    Non-operating income (expense):           
    Interest expense(3,040) (600) (6,163) (1,172)
    Gain (loss) from change in fair value of derivatives30,829  20  21,216  (306)
    Interest and other income (expense), net(53) 342  (405) 725 
                
    Income (loss) before income taxes18,111  (9,003) 1,493  (19,898)
    Income tax expense(740) (551) (1,890) (1,274)
                
    Net income (loss)$17,371  $(9,554) $(397) $(21,172)
                
    Net income (loss) per share of Common Stock:           
    Basic$0.11  $(0.10) $(0.00) $(0.24)
    Diluted$(0.04) $(0.10) $(0.08) $(0.24)
                
    Weighted average number of shares of Common Stock outstanding:           
    Basic143,636  93,003  135,534  89,187 
    Diluted170,609  93,003  166,323  89,187 
                

     

    NewAge, Inc.
    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    SIX MONTHS ENDED JUNE 30, 2021 AND 2020
    (In thousands)
          
     2021 2020
          
    CASH FLOWS FROM OPERATING ACTIVITIES:     
    Net loss$          (397) $       (21,172)
    Adjustments to reconcile net loss to net cash used in operating activities:     
    Loss (gain) from change in fair value of derivatives, net(21,216) 306 
    Depreciation and amortization9,596  3,752 
    Non-cash lease expense6,244  2,792 
    Loss on disposal of Divested Business-  - 
    Accretion of debt discount4,372  302 
    Stock-based compensation expense4,149  2,449 
    Allowance for uncollectible note receivable from Divested Business2,701  - 
    Impairment of right-of-use assets-  400 
    Expense for make-whole premium and other-  - 
    Deferred income tax benefit(149) (173)
    Loss from sale of property and equipment60  66 
    Other118  73 
    Changes in operating assets and liabilities, net of effects of business combination:     
    Accounts receivable(37) (2,276)
    Inventories4,681  2,819 
    Prepaid expenses, deposits and other1,640  517 
    Accounts payable(5,840) (551)
    Other accrued liabilities(11,482) (12,900)
          
    Net cash used in operating activities(5,560) (23,596)
          
    CASH FLOWS FROM INVESTING ACTIVITIES:     
    Cash payments for Ariix business combination(10,000) - 
    Proceeds from sale of equipment-  159 
    Capital expenditures for property and equipment(765) (1,980)
    Net cash used in investing activities(10,765) (1,821)
          
    CASH FLOWS FROM FINANCING ACTIVITIES:     
    Proceeds from private placement of Units, net of placement fee:     
    Fair value of warrants to purchase 7,318 shares of Common Stock14,128  - 
    Residual fair value of 14,636 shares of Common Stock39,673  - 
    Proceeds from borrowings-  6,868 
    Principal payments on borrowings(6,000) (10,450)
    Debt issuance costs paid(21) (85)
    Proceeds from issuance of common stock-  25,122 
    Payments for deferred offering costs(24) (94)
    Proceeds from exercise of stock options528  4 
    Principal payments on business combination obligations(4,496) (298)
    Payments under deferred lease financing obligation(329) (319)
          
    Net cash provided by financing activities43,459  20,748 
          
    Effect of foreign currency translation changes90  (857)
          
    Net change in cash, cash equivalents and restricted cash27,224  (5,526)
    Cash, cash equivalents and restricted cash at beginning of period65,235  64,571 
          
    Cash, cash equivalents and restricted cash at end of period$      92,459  $        59,045 



     Three Months Ended Six Months Ended
     June 30, June 30,
     2021 2020 2021 2020
                
    Net income (loss)$     17,371  $    (9,554) $        (397) $    (21,172)
    EBITDA Non-GAAP adjustments:           
    Interest expense         3,040            600           6,163            1,172 
    Income tax expense            740            551           1,890            1,274 
    Depreciation and amortization  expense         4,822         1,873           9,596            3,752 
                
    EBITDA       25,973        (6,530)        17,252        (14,974)
    Adjusted EBITDA Non-GAAP adjustments:           
    Stock-based compensation expense         2,187         1,092           4,149            2,449 
    Loss on disposal of Divested Business         4,339                 -           4,339                    - 
    Loss (gain) from change in fair value of derivatives      (30,829)            (20)      (21,216)              306 
                
    Adjusted EBITDA $       1,670  $    (5,458) $       4,524  $    (12,219)
                

    Non-GAAP Financial Measures

    The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.

    _________________________________

    1EBITDA and Adjusted EBITDA are non-GAAP financial measures with reconciliations provided in the table below. 



    Primary Logo

    Get the next $NBEV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NBEV

    DatePrice TargetRatingAnalyst
    8/10/2021$6.50 → $6.00Buy
    Roth Capital
    More analyst ratings

    $NBEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital reiterated coverage on NewAge with a new price target

    Roth Capital reiterated coverage of NewAge with a rating of Buy and set a new price target of $6.00 from $6.50 previously

    8/10/21 9:23:04 AM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    $NBEV
    SEC Filings

    View All

    NewAge Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - NewAge, Inc. (0001579823) (Filer)

    9/15/22 5:00:37 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 25-NSE filed by NewAge Inc.

    25-NSE - NewAge, Inc. (0001579823) (Subject)

    9/14/22 9:52:26 AM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    NewAge Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - NewAge, Inc. (0001579823) (Filer)

    9/2/22 5:22:14 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    $NBEV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $NBEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    NewAge, Inc. Announces Sale of Legacy Direct Store Distribution Division

    SALT LAKE CITY, Sept. 09, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (OTC:NBEVQ) (the "Company"), the Utah-based direct-to-consumer (D2C) organic and healthy products company, today announced that its wholly-owned subsidiaries, NABC, Inc. and NABC Properties, LLC (together, "NABC"), have entered into a definitive agreement to sell the legacy direct store distribution ("DSD") division to Legacy Distribution Group, a Colorado-based distribution company. The transaction is expected to be completed in the fourth quarter of 2022, and closing will be subject to court approval in the Company's pending bankruptcy case. The Company believes the DSD business is one of the largest independent distributo

    9/9/22 4:01:35 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    NewAge, Inc. Announces That Its Common Stock Has Ceased Trading on Nasdaq

    SALT LAKE CITY, Sept. 08, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (the "Company") today announced that its common stock has been suspended from trading on The Nasdaq Stock Market due to its voluntary filing for relief under Chapter 11 of the United States Bankruptcy Code on August 30, 2022 and the Company's inability to remain compliant with the listing requirements of The Nasdaq Stock Market. As previously disclosed, the Company does not intend to appeal the suspension and anticipated delisting of its stock from The Nasdaq Stock Market. Effective September 8, 2022, the Company's common stock is expected to begin trading on the OTC Market under the trading symbol "NBEVQ." Investors can find

    9/8/22 3:30:12 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    NewAge, Inc. Receives Court Approval of First Day Motions

    SALT LAKE CITY, Sept. 02, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV) (the "Company") today announced that the U.S. Bankruptcy Court for the District of Delaware has granted the Company interim approval for first day motions related to its Chapter 11 restructuring. The approved motions will support the Company's ongoing operations during its financial restructuring process. The Court granted the Company access to a debtor-in-possession ("DIP") financing facility of $16 million provided by DIP Financing, LLC, which combined with the Company's projected revenues, will support its operations during the Chapter 11 process. The Court has also authorized the Company to continue paying

    9/2/22 5:33:59 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 3 filed by new insider Crocker Michele

    3 - NewAge, Inc. (0001579823) (Issuer)

    3/16/22 7:11:45 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 3: New insider Hammerschmidt Judith Lynne claimed no ownership of stock in the company

    3 - NewAge, Inc. (0001579823) (Issuer)

    12/10/21 11:52:48 AM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 4: Cooper Fred W was granted 11,968,470 shares

    4 - NewAge, Inc. (0001579823) (Issuer)

    11/23/21 5:25:14 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    $NBEV
    Leadership Updates

    Live Leadership Updates

    View All

    NewAge, Inc. Announces Departure of Chief Financial Officer and Appointment of Principal Financial Officer

    SALT LAKE CITY, July 08, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV) (the "Company" or "NewAge"), today announced that Kevin Manion, Chief Financial Officer, departed the Company as of July 1, 2022. Lawrence Perkins, who along with his firm SierraConstellation Partners LLC have been engaged to provide Chief Restructuring Officer (CRO) and other services to the Company, will assume the role of the Company's principal financial officer on an interim basis. "On behalf of NewAge, I want to thank Kevin for his contributions to our team. Kevin joined us in the middle of a major integration, and he resolved many operating issues for us. We wish him all the best," said Ed Brennan, NewAge'

    7/8/22 6:00:00 AM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    NewAge, Inc. Appoints Michele Crocker to its Board of Directors

    SALT LAKE CITY, March 03, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), a direct selling company with a primary focus on healthy products, today announced the appointment of Michele Crocker to its Board of Directors. "I am delighted to welcome Michele to our Board of Directors," said Ed Brennan, Chairman of NewAge's Board. "Her strong background in the direct selling industry and her expertise in implementing programs that significantly improve recruitment, retailing and retention, will complement our existing Board and provide important insights into developing our most valuable asset – our Brand Partners." Ms. Crocker is Chief Operating Officer at CIENCE, a data company offering

    3/3/22 6:00:00 AM ET
    $HLF
    $NBEV
    Other Pharmaceuticals
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    NewAge, Inc. Appoints Judith Hammerschmidt to Board of Directors

    DENVER, Dec. 01, 2021 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), the Colorado-based direct-to-consumer (D2C) organic and healthy products company, announced today the appointment of Judith Hammerschmidt to its Board of Directors. "Judy has an impressive background having spent many years as outside counsel and as a board member helping companies expand in highly regulated industries," said Brent Willis, NewAge's Chief Executive Officer. "We enthusiastically welcome Judy to our Board and look forward to drawing upon her broad experience as we continue our growth and expansion for the benefit of our many stakeholders." Ms. Hammerschmidt has more than three decades of experience in cor

    12/1/21 4:05:00 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    $NBEV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NewAge Inc.

    SC 13G - NewAge, Inc. (0001579823) (Subject)

    7/8/22 4:56:55 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form SC 13G/A filed by NewAge Inc. (Amendment)

    SC 13G/A - NewAge, Inc. (0001579823) (Subject)

    2/3/22 4:41:33 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    $NBEV
    Financials

    Live finance-specific insights

    View All

    NewAge, Inc. Delays Fourth Quarter and Full Year 2021 Financial Results Conference Call

    SALT LAKE CITY, March 15, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), a direct selling company with a primary focus on healthy products, today announced its fourth quarter and full year 2021 earnings release and conference call will be rescheduled to allow additional time to complete its Annual Report on Form 10-K. The Company will be filing a Form 12b-25, Notification of Late Filing, on March 16, 2022, which will provide the Company with a 15-day extension to file its Form 10-K. The Company expects to report financial results for the quarter and full year ended December 31, 2021, on or before March 31, 2022, the expiration date of the extension period. Updated conference call det

    3/15/22 4:05:00 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    NewAge, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 16

    SALT LAKE CITY, Feb. 25, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), a direct-to-consumer (D2C) healthy products company, today announced that it will release financial results for its fourth quarter and full year ended December 31, 2021, after the market close on Wednesday, March 16, 2022. A conference call and audio webcast with analysts and investors will be held that afternoon at 5:00 p.m. Eastern Time/3:00 p.m. Mountain Time to discuss the results and answer questions. Live conference call: 1-877-407-3982 (domestic) or 1-201-493-6780 (international) with conference ID: 13727435.Live and archived webcast will be available here and on the Events page of NewAge's investor rela

    2/25/22 6:05:00 AM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples

    NewAge, Inc. Announces Third Quarter 2021 Financial Results With Revenue Growth of 59%

    DENVER, Nov. 09, 2021 (GLOBE NEWSWIRE) -- NewAge, Inc. (NASDAQ:NBEV), the Colorado-based direct-to-consumer (D2C) organic and healthy products company, today announced financial results for the third quarter of 2021. Third Quarter 2021 Highlights -Net revenue increased 59% to $100 million compared to $63 million in the third quarter of 2020 -Gross profit was $66 million compared to $37 million in the prior year third quarter, an increase of $29 million -Gross margin reached 66.3% of net revenue compared to 59.8% of revenue in the prior year third quarter, up 6.5 points -Net income improved $11.4 million to ($2.7) million, or ($0.02) per basic share -Adjusted EBITDA1 improved $4.0 million t

    11/9/21 4:01:00 PM ET
    $NBEV
    Beverages (Production/Distribution)
    Consumer Staples